Literature DB >> 6131586

Diazepam versus lorazepam: relationship of drug distribution to duration of clinical action.

D J Greenblatt, M Divoll.   

Abstract

Eight healthy volunteers received single intravenous doses of diazepam and lorazepam on two separate occasions. Kinetic parameters of drug distribution and clearance were determined by measurement of multiple plasma concentrations following each dose. Elimination half-life for diazepam averaged 51.2 hr, as compared with 15.7 hr for lorazepam. However, after correction for individual differences in protein binding (mean free fraction 1.5% for diazepam versus 10.1% for lorazepam), the volume of distribution of unbound diazepam (mean 133 liter/kg) was more than 10 times larger than that of lorazepam (mean 12 liter/kg). This is consistent with in vivo measurements of lipid solubility indicating that diazepam has a much larger octanol/water partition coefficient than lorazepam. Thus, the shorter duration of action of a single intravenous dose of diazepam as compared with lorazepam, despite the much longer half-life of diazepam, is explained by the more extensive tissue distribution of unbound diazepam.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6131586

Source DB:  PubMed          Journal:  Adv Neurol        ISSN: 0091-3952


  11 in total

Review 1.  Emergency department drug therapy for status epilepticus in adults.

Authors:  A S Lockey
Journal:  Emerg Med J       Date:  2002-03       Impact factor: 2.740

2.  Recent and future advances in the treatment of status epilepticus.

Authors:  Felix Rosenow; Susanne Knake
Journal:  Ther Adv Neurol Disord       Date:  2008-07       Impact factor: 6.570

Review 3.  Outpatient pharmacotherapy and modes of administration for acute repetitive and prolonged seizures.

Authors:  Heather Ravvin McKee; Bassel Abou-Khalil
Journal:  CNS Drugs       Date:  2015-01       Impact factor: 5.749

Review 4.  Diazepam in the Treatment of Moderate to Severe Alcohol Withdrawal.

Authors:  Steven J Weintraub
Journal:  CNS Drugs       Date:  2017-02       Impact factor: 5.749

5.  Comparison of the effects of quazepam and triazolam on cognitive-neuromotor performance.

Authors:  A M Nikaido; E H Ellinwood
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

6.  Benzodiazepine pharmacodynamics: evidence for biophase rate limiting mechanisms.

Authors:  E H Ellinwood; A M Nikaido; D G Heatherly; T D Bjornsson
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

7.  Status epilepticus: current treatment strategies.

Authors:  Edward M Manno
Journal:  Neurohospitalist       Date:  2011-01

Review 8.  Intravenous and Intramuscular Formulations of Antiseizure Drugs in the Treatment of Epilepsy.

Authors:  Sima I Patel; Angela K Birnbaum; James C Cloyd; Ilo E Leppik
Journal:  CNS Drugs       Date:  2015-12       Impact factor: 5.749

9.  Withdrawal-induced delirium associated with a benzodiazepine switch: a case report.

Authors:  Herbert Bosshart
Journal:  J Med Case Rep       Date:  2011-05-26

10.  Effects of Several Therapeutic Agents on Mammalian Vestibular Function: Meclizine, Diazepam, and JNJ7777120.

Authors:  Choongheon Lee; Timothy A Jones
Journal:  J Assoc Res Otolaryngol       Date:  2021-05-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.